IBC Research Fdn
@IBCResearch
Followers
2K
Following
35K
Media
1K
Statuses
14K
Web-based, all volunteer non-profit working to improve the lives of those touched by inflammatory breast cancer (IBC) through the power of advocacy & action.
Broadway, VA 22815
Joined August 2013
TY to #SylviaPowers of National Consortium of Breast Centers for getting this info out to folks who need to know about #IBC
https://t.co/xZLL1ZgVkR
texasmetronews.com
By Sylvia PowersCorrespondentTexas Metro News Inflammatory breast cancer (IBC) is among the most aggressive and deadly forms of breast cancer—yet it remains one of the least understood, especially in...
0
0
0
Stats for BC aren't very reliable. They're often based on a single institution (could look overly optimistic) or SEER data, which might show the opposite. These data aren't current so understand that YOU are not a statistic. My prognosis was 12-18 mo. That was 31 years ago!
0
0
1
As #pinkoctober winds down, I hope you've learned the importance of paying attention to your body, that not all breast cancer has a lump and evidence-based treatment is needed when dealing with cancer. Learn more at https://t.co/6C7S6iZjnZ
0
2
4
It is long past the time when people should be excluded from trials due to brain mets. Did you know that brain metastasis is more common than primary brain tumors?
Brain metastases are usually diagnosed by MRI. When cancer spreads to the meninges or cerebrospinal fluid, it’s called leptomeningeal disease—a particularly difficult form to treat. We need more research—and trials that include people with brain mets. #UntilNoOneDiesFromMBC
0
4
18
Tylenol Maker Fights Autism Warning Label, Citing Lack of Scientific Evidence
empr.com
The maker of Tylenol is urging the FDA to reject autism warning requests for the drug's use in pregnancy.
0
0
0
Before 'standard of care' for #IBC survival was 12-18 mo. Since then, we've learned that #chemofirst works best for aggressive breast cancers like #IBC. Speak up if your doctor suggests surgery first....or find a new treatment team!!
0
0
1
DESTINY Breast 05 presented at #ESMO25 Study breakdown T-DXd-THP in high-risk HER2+ 🧬early #BreastCancer Results mirrored Breast11 — a pCR rate of 67% vs 56% and a favorable safety profile with less grade ≥3 toxicity and less cardiotoxicity. @matteolambe @aftimosp
0
16
26
ASCENT 03 presented at #ESMO25 Study breakdown In #TNBC #BreastCancer , the ASCENT-03 trial assessed sacituzumab govitecan in previously untreated patients ineligible for PD-1 or PD-L1 inhibitors. The ADC improved progression-free survival from 6.9 to 9.7 months, with more
0
13
23
Inluriyo Approved for ER , HER2-, iESR1/i-Mutated #Metastatic #BreastCancer
cancertherapyadvisor.com
Imlunestrant significantly reduced the risk of progression or death by 38% vs investigator’s choice of endocrine therapy.
0
0
0
NEWS FROM Industry: HER2CLIMB-05 Update Source: Pfizer announcement, report by Business wire OncoAlert 🚨
NEWS FROM Industry: HER2CLIMB-05 Update Source: Pfizer announcement, report by Business wire https://t.co/P75uFNuhpI Pfizer announced positive topline results from the Phase 3 HER2CLIMB-05 trial, which evaluated the addition of the tyrosine kinase inhibitor tucatinib to
1
4
28
📣 In 68K women in 🇺🇸 case-control studies in CARRIERS consortium: those w/ pathogenic mutation plus a 1st degree relative w/ #breastcancer had 23% risk of BC by age 50 & 51% risk from age 50-80 (vs 9% & 30% for those w/ just a mutation). Esp striking w/ PALB2. #bcsm #MedTwitter
We are excited to share results from our recently published article in @JAMAOnc In this study of 67,692 U.S. women, we identify that carriers of germline pathogenic variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2 and a first-degree family history of breast cancer had a higher risk
1
6
20
It's hard to advocate 4 yourself, u need to learn first! Visit https://t.co/6C7S6iZRdx for info & experience with #IBC direct them to https://t.co/3rLqbY5GEo for guidelines developed by physicians for physicians. (check out the patient guide they offer as well) #Youareworthit
0
1
2
Oct 16 was #NationalMammogramDay. While they can be useful, they seldom pick up #IBC. Don't let a Dr dismiss your concerns just because they didn't see a lump. YOU know your body, so keep pushing for answers. #AdvocateforYourself
0
1
3
Largest evacuation in recent memory underway after devastating Alaska flooding https://t.co/Um66xgnJjN Our hearts go out to these folks in #Alaska...can only imagine their challenges now and in the coming weeks.
0
0
2
7% of physicians say the #priorauth requirements in health insurance contribute to their patients' deaths. Remind me again why we have health insurance at all?
@double_whammied Yes we presented our work at #ASCOQLTY25 yesterday showing that 7% of physicians said that #priorAuth contributed to patient death
0
1
3
Dear Colleagues at #ESMO25 An honor to introduce our @OncoAlert 🚨Faculty @delmastro_lucia 🇮🇹 discussing the results of #monarchE 🦋 in #BreastCancer Presentati a #ESMO25 i risultati aggiornati dello studio monarchE che dimostrano come abemaciclib nel trattamento adiuvante
1
17
25
Medicaid Expansion Linked to Improved Survival Outcomes in #Cancer Patients
cancertherapyadvisor.com
Survival benefits were seen in patients in rural or high-poverty communities, as well as in patients with a cancer generally linked to a worse prognosis, study researchers reported.
0
1
1
Last year I shared there was no IBC specific ICD code making it hard to obtain accurate #s of ppl dx with IBC. Thanks to efforts of the #IBCCollaborative, we made that happen! Share this info with HCPs & don't forget to tell them about the #IBC Diagnostic Scoring Scale as well!
0
0
0